Sonoma Developer Oakmount Senior Living Marries Architecture With Nature to Recreate Tuscany ... ( Demand for Finer Senior Liv...)

Sonoma Developer Oakmount Senior Living Marries Architecture With Nature to Recreate Tuscany at Varenna

Date:5/27/2008

Demand for Finer Senior Living Expected in Coming Years

SANTA ROSA, Calif., May 27 /PRNewswire/ -- Nature provided the idyllic climate and scenery at Varenna. Oakmont Senior Living LLC did the rest. Varenna is a perfect example of a development that benefits from 25 years of experience in every facet of senior residence design and construction.

The luxurious new continuing care residential community sets a grand and unparalleled stage for retirement. From classical cast stone columns to arched patios and wrought iron railings to hand-carved beams, Varenna marries an amazing location, exquisite designs and first-class services and amenities for seniors of all ages.

Its goal: Create a community that infuses everyday retirement living with the ease and elegance of a five-star Italian resort. "We wanted the design to reflect the Tuscany region and give our residents the feeling of vacationing at home," said William P. Gallaher, Oakmont's president and CEO and a Sonoma County native. "Our experience as a senior living builder let us recreate the feel of the region and still build with the specific needs and interests of our residents in mind."

With an eye to building for the next generation of retirees, the picturesque property was purchased in 2002. Demographics point to significant growth in CCRC's. Their appeal is obvious. They provide a much needed stage in retirement living that until now hasn't been met. They want to live a healthy, vibrant lifestyle and communities like Varenna provide that along with safety.

"As the boomers are aging they want choices. Varenna caters to people who are looking for a level of service and lifestyle that embraces the best life can give, and we have meet that expectation and then some," says Gallaher.

Groundbreaking occurred in 2005 and since thousands of local employees have benefited including local subcontractors. Varenna employs about 60 people, not counting the local companie
'/>"/>

SOURCE Oakmont Senior Living LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Microsoft Health & Life Sciences Developer and Solutions Conference to Feature the Latest Microsoft-Based Software Solutions
2. Stem Cell Technology Offers Promise of Huge Savings for Drug Developers
3. Awake the Movie Highlights the Need for Goldilocks Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R)
4. Susan G. Komen for the Cure Partners With the Original Butter Bell(R) Crock Developer
5. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
6. AHCA, Alliance Warn Rural Seniors Will Bear Major Brunt of Bush Administrations Medicare Cuts
7. SCAN Health Plan Offers Seniors Ten Tips for Safe and Healthy Travel
8. PartnerRe Ltd. to Issue $250 million in 6.875% Senior Notes
9. ACM Taps Two Senior Leaders to Head Up New Strategic Initiatives
10. Emdeon Business Services Names Miriam Paramore Senior Vice President of Corporate Strategy
11. Best Practices Insurance Services Announces Key Additions to Senior Management

Post Your Comments:

(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also

(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be

(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa

(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa

(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju

Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2 Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2 Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3 Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2 Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3 Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4 Health News:Human guinea pigs wary of high-paying medical trials 2 Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2

[0] Free Health Clinic Event Is Not Just for the Sick [0] The Leapfrog Group Releases Its 2009 Top Hospitals List [0] Muscle cell infusion shown to strengthen sphincters in animals in Stanford study [0] Human guinea pigs wary of high-paying medical trials [0] Timing of Multiple-Ligament Knee Surgery May Not Matter

... WEDDLE,s, the largest publisher of print gu...009 User,s Choice Awards. Absolutely Health Care, ...d medical jobs is pleased to receive this prestigi...ere actual users such as job seekers, employers, a...

... Company leads industry in providing medical...e Base tool. , Lake Fores...e Technologies announces a comprehensive initiativ...rt of Scribe,s continuing strategy to provide tran...

... SpectraScience, Inc. (OTC Bulletin Board: SCIE), ...d today that it has entered into a $6.0 million co...Fund II, LLC, a Chicago-based institutional invest... the Securities and Exchange Commission has declar...

...., Feb. 4 drugstore.com , inc.,(Nasdaq: DSCM )...ion, and,pharmacy products, today announced its fi...year ended December 28, 2008. The company reporte...d EBITDA,in the history of the company of $5.2 mil...

...4 The Elton John AIDS Foundation announced today ...erform at the 17th Annual Elton John AIDS Foundati...y, February 22, 2009, at the Pacific Design Center...h1. , , Oakland native Raphael Saadiq made his en...

...red Hispanic children will receive coverage , , W...ignificant downpayment on his commitment to make h... L. Delgado, President and CEO of the National All...ize the State Children,s Health Insurance Program ...

For the Third Year in a Row, Absolutely Health Care is Awarded a WEDDLE's User's Choice Award Scribe Healthcare Technologies, LLC to Integrate BenchMark KB™ in Scribe Complete™ Medical Documentation Platform SpectraScience, Inc. Enters Into $6.0 Million Common Stock Purchase Agreement drugstore.com inc. Reports Profitable Fourth Quarter of 2008 and Free Cash Flow of $5.4 Million on Record OTC Sales Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party SCHIP Brings Relief to Modest-Income Families

(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is

(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square

(Date:12/3/2009)HOERSHOLM, Denmark and SAN DIEGO, California, December 3 , - SPC3649 Successfully Inhibits miR-122, a microRNA Important for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatiti

Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2 Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3 BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2 BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3 New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2 New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3 New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4 New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5 Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 1 Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 2 Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 3 Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 4 Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 5 Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 6 Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 7 Stent Studies Tied to Rapid Changes in Use 52992 1 Stent Studies Tied to Rapid Changes in Use 52992 2 DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 1 DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 2

[0] Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition [0] BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark [0] New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C

...27 A doctor who is,internationally recognized for...cally for research on DHA, an omega-3 fatty acid, ...d for outstanding achievement in the field,of mate...as among the first to report that infants,receivin...oic acid) levels,than formula-fed infants and the ...

...ur Years of Treatment Presented at ICAAC/IDSA,2008...ough,Corporation (NYSE: SGP ) today reported a da...tional CCR5 receptor antagonist, demonstrated,sust...nts and was well,tolerated through up to four year... patients. Vicriviroc was administered once-daily ...

Other Medicine Technology:March of Dimes Honors Dr. Susan Carlson for Outstanding Work In Maternal-Fetal Nutrition 2 Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 2 Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 3 Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 4 Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 5 Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 6

March of Dimes Honors Dr. Susan Carlson for Outstanding Work In Maternal-Fetal Nutrition Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients

DNA Engine Thermal Cycler Chassis, w/96-well block & motorized lid

DNA Engine Thermal Cycler Chassis

MBS Satellite Thermal Cycler 0.5ml

MBS Satellite Thermal Cycler 0.2ml

Medicine Products:

DNA Engine Thermal Cycler Chassis, w/96-well block & motorized lid DNA Engine Thermal Cycler Chassis MBS Satellite Thermal Cycler 0.5ml MBS Satellite Thermal Cycler 0.2ml

Sonoma Developer Oakmount Senior Living Marries Architecture With Nature to Recreate Tuscany ...( Demand for Finer Senior Liv...),Health